Enter Your Search:
Results 1-2 (2)
Go to page number:
Clear All Filters
Journal of Biomolecular Screening (1)
Journal of biomolecular screening (1)
Chapnick, Douglas A. (1)
Jacob, Renju T. (1)
Kirchhoff, Paul D. (1)
Kuchta, Robert D. (1)
Larsen, Martha J. (1)
Larsen, Scott D. (1)
Liu, Xuedong (1)
Nasveschuk, Christopher G. (1)
Neubig, Richard R. (1)
Parker, Seth J. (1)
Phillips, Andrew J. (1)
Sherman, David H. (1)
Ungermannova, Dana (1)
Year of Publication
MScreen: An Integrated Compound Management and High Throughput Screening (HTS) Data Storage and Analysis System
Jacob, Renju T.
Larsen, Martha J.
Larsen, Scott D.
Kirchhoff, Paul D.
Sherman, David H.
Neubig, Richard R.
Journal of biomolecular screening
High-throughput screening (HTS) has historically been used by the pharmaceutical industry to rapidly test hundreds of thousands of compounds to identify potential drug candidates. More recently, academic groups have used HTS to identify new chemical probes or small interfering RNA (siRNA) that can serve as experimental tools to examine the biology or physiology of novel proteins, processes, or interactions. HTS presents a significant challenge with the vast and complex nature of data generated. This report describes MScreen, a web-based, open-source cheminformatics application for chemical library and siRNA plate management, primary HTS and dose-response data handling, structure search, and administrative functions. Each project in MScreen can be secured with passwords or shared in an open information environment which enables collaborators to easily compare data from many screens, providing a useful means to identify compounds with desired selectivity. Unique features include compound, substance, mixture, and siRNA plate creation and formatting; automated dose-response fitting and quality control (QC); and user, target, and assay method administration. MScreen provides an effective means to facilitate HTS information handling and analysis in the academic setting so that users can efficiently view their screening data and evaluate results for follow-up.
chemoinformatics; data analysis software; open source; high-throughput screening
Identification and Mechanistic Studies of a Novel Ubiquitin E1 Inhibitor
Parker, Seth J.
Nasveschuk, Christopher G.
Chapnick, Douglas A.
Phillips, Andrew J.
Kuchta, Robert D.
Journal of Biomolecular Screening
Protein degradation via the ubiquitin-proteasome pathway is important for a diverse number of cellular processes ranging from cell signaling to development. Disruption of the ubiquitin pathway occurs in a variety of human diseases, including several cancers and neurological disorders. Excessive proteolysis of tumor suppressor proteins, such as p27, occurs in numerous aggressive human tumors. To discover small-molecule inhibitors that potentially prevent p27 degradation, we developed a series of screening assays, including a cell-based screen of a small-molecule compound library and two novel nucleotide exchange assays. Several small-molecule inhibitors, including NSC624206, were identified and subsequently verified to prevent p27 ubiquitination in vitro. The mechanism of NSC624206 inhibition of p27 ubiquitination was further unraveled using the nucleotide exchange assays and shown to be due to antagonizing ubiquitin activating enzyme (E1). We determined that NSC624206 and PYR-41, a recently reported inhibitor of ubiquitin E1, specifically block ubiquitin-thioester formation but have no effect on ubiquitin adenylation. These studies reveal a novel E1 inhibitor that targets a specific step of the E1 activation reaction. NSC624206 could, therefore, be potentially useful for the control of excessive ubiquitin-mediated proteolysis in vivo.
ubiquitin E1; inhibitor; p27kip1; ubiquitin; proteolysis
Results 1-2 (2)
Go to page number:
Remove citation from clipboard
Add citation to clipboard
This will clear all selections from your clipboard. Do you wish proceed?
Clipboard is full! Please remove an item and try again.
PubMed Central Canada is a service of the
Canadian Institutes of Health Research
(CIHR) working in partnership with the National Research Council's
Canada Institute for Scientific and Technical Information
in cooperation with the
National Center for Biotechnology Information
U.S. National Library of Medicine
(NCBI/NLM). It includes content provided to the
PubMed Central International archive
by participating publishers.